Roles of ApoE4 on the Pathogenesis in Alzheimer’s Disease and the Potential Therapeutic Approaches

被引：0
|
作者：
Yu-Ying Sun
Zhun Wang
Han-Chang Huang
机构：
[1] Beijing Union University,Beijing Key Laboratory of Bioactive Substances and Functional Foods
[2] Beijing Union University,Key Laboratory of Natural Products Development and Innovative Drug Research
来源：
Cellular and Molecular Neurobiology | 2023年 / 43卷
关键词：
Apolipoprotein E4 (ApoE4); Alzheimer’s disease (AD); β-Amyloid (Aβ); Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3115 / 3136
页数：21
相关论文
共 50 条
  • [21] Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation
    Ana C. Valencia-Olvera
    Deebika Balu
    Naomi Faulk
    Aspasia Amiridis
    Yueting Wang
    Christine Pham
    Eva Avila-Munoz
    Jason M. York
    Gregory R. J. Thatcher
    Mary Jo LaDu
    [J]. Neurotherapeutics, 2023, 20 : 1120 - 1137
  • [22] Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease
    Vance, Jeffery M.
    Farrer, Lindsay A.
    Huang, Yadong
    Cruchaga, Carlos
    Hyman, Bradley T.
    Pericak-Vance, Margaret A.
    Goate, Alison M.
    Greicius, Michael D.
    Griswold, Anthony J.
    Haines, Jonathan L.
    Julia, T. C. W.
    Schellenberg, Gerard D.
    Tsai, Li-Huei
    Herz, Joachim
    Holtzman, David M.
    [J]. ANNALS OF NEUROLOGY, 2024, 95 (04) : 625 - 634
  • [23] Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease
    Theendakara, Veena
    Peters-Libeu, Clare A.
    Bredesen, Dale E.
    Rao, Rammohan V.
    [J]. MOLECULAR NEUROBIOLOGY, 2018, 55 (06) : 5243 - 5254
  • [24] Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease
    Veena Theendakara
    Clare A. Peters-Libeu
    Dale E. Bredesen
    Rammohan V. Rao
    [J]. Molecular Neurobiology, 2018, 55 : 5243 - 5254
  • [25] Drugs targeting APOE4 that regulate beta-amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease
    Poblano, Joan
    Castillo-Tobias, Ileana
    Berlanga, Lia
    Tamayo-Ordonez, Maria Concepcion
    Rodriguez-Salazar, Maria del Carmen
    Silva-Belmares, Sonia Yesenia
    Aguayo-Morales, Hilda
    Cobos-Puc, Luis E.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 (03) : 237 - 249
  • [26] Cellular Senescence and ApoE4: Their Repercussions in Alzheimer's Disease
    Tecalco-Cruz, Angeles C.
    Zepeda-Cervantes, Jesus
    Lopez-Canovas, Lilia
    Oriando Ramirez-Jarquin, Josue
    Pedraza-Chaverri, Jose
    Briones-Herrera, Alfredo
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2021, 20 (09) : 778 - 785
  • [27] Development of ApoE4 targeted therapy of Alzheimer's disease
    Michaelson, D. M.
    Luz, I
    Liraz, O.
    Boehm, A.
    Smorodinsky, N., I
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S81 - S81
  • [28] mTOR: Alzheimer's disease prevention for APOE4 carriers
    Lin, Ai-Ling
    Butterfield, D. Allan
    Richardson, Arlan
    [J]. ONCOTARGET, 2016, 7 (29) : 44873 - 44874
  • [29] Is Understanding Alzheimer's as Easy as (Aβ) C?: The Role of Aβ and APOE4 in Alzheimer's Disease
    Lane, Jim
    Mckusick, Alexa
    Daniels, Ella
    Brown, Abigail
    Burge, Caroline
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S95 - S95
  • [30] Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease
    Martiskainen, Henna
    Haapasalo, Annakaisa
    Kurkinen, Kaisa M. A.
    Pihlajamaki, Jussi
    Soininen, Hilkka
    Hiltunen, Mikko
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 781 - 794
12345